Inovio Pharmaceuticals Inc (NAS:INO)
$ 11.11 -0.89 (-7.42%) Market Cap: 287.87 Mil Enterprise Value: 218.74 Mil PE Ratio: 0 PB Ratio: 2.75 GF Score: 48/100

Q1 2022 Inovio Pharmaceuticals Inc Earnings Call Transcript

May 10, 2022 / 08:30PM GMT
Release Date Price: $29.88 (+5.06%)
Operator

Good afternoon, and welcome to the Inovio Pharmaceuticals First Quarter 2022 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Ben Matone, Senior Director of Investor Relations. Please go ahead.

Ben Matone
Inovio Pharmaceuticals, Inc. - Director of IR

Thank you, operator. Good afternoon, and thank you for joining the Inovio First Quarter 2022 Earnings Conference Call. Joining me on today's call are Dr. Jacqui Shea, President and CEO; Mr. Peter Kies, Chief Financial Officer; Dr. Laurent Humeau, Chief Scientific Officer; Mark Twyman, Chief Commercial Officer; Dr. David Liebowitz, Senior Vice President of Clinical Development for Infectious Diseases; and Dr. Jeffrey Skolnik, Senior Vice President of Clinical Development for Oncology and HPV Therapeutics.

For today's call, we will review our corporate and financial information for the quarter ended March 31, 2022, as well as provide an update on our efforts across our DNA medicines platform.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot